Replies to post #508507 on Anavex Life Sciences Corp (AVXL)

[pcguy]

I think this could be a little closer to the issue, variability. I haven't read the ABClear publication, but from comments I gather that post-hoc analysis clarified this variability into subgroups.

[gerry57]

It doesn’t seem possible that they don’t have biomarker data matched to genetic disposition from the beginning of the trial to the end of ole including of course placebo late starters

[frrol]

Correct, the mean differences on those charts are very big, so their variance intervals must be huge.